Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 01/16 05:35:00 pm
1580.5 GBp   -0.32%
01/10DJMAYNE PHARMA : Launches Foam Dermatology Products in US
01/05 BAT quits nicotine inhaler to focus on vaping
01/05 BAT quits nicotine inhaler to focus on vaping
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Sales26 50523 00623 92327 54929 39530 470
Operating income (EBITDA)8 8838 0457 0289 29310 06310 524
Operating profit (EBIT)8 0156 5945 7297 2258 0888 581
Pre-Tax Profit (EBT)6 6472 96810 5263 5646 5837 447
Net income5 6282 7568 4222 3114 2184 921
P/E ratio14,624,37,9733,519,417,1
EPS (GBp )11156,717247,381,793,0
Dividend per Share (GBp )78,080,080,081,180,481,0
Yield4,84%5,81%5,83%5,11%5,07%5,11%
Reference price (GBp )1611.5137613731585.51585.51585.5
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Debt12 64514 37710 72713 80513 23812 301
Finance------
Operating income (EBITDA)8 8838 0457 0289 29310 06310 524
Leverage
(Debt/EBITDA)
1,42x1,79x1,53x1,49x1,32x1,17x
Capital Expenditure1 1881 1881 3801 5621 5451 551
Book Value Per Share (BVPS)146 PNC87,6 PNC106 PNC60,8 PNC54,0 PNC70,5 PNC
Cash Flow per Share149 PNC108 PNC53,2 PNC116 PNC141 PNC150 PNC
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 77 850 M GBP -
Entreprise Value (EV) 91 655 M GBP 91 088 M GBP
Valuation 2016e 2017e
P/E ratio (Price / EPS) 33,5x 19,4x
Capitalization / Revenue 2,83x 2,65x
EV / Revenue 3,33x 3,10x
EV / EBITDA 9,86x 9,05x
Yield (DPS / Price) 5,11% 5,07%
Price to book (Price / BVPS) 26,1x 29,3x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 26,2% 27,5%
operating Leverage (Delta EBIT / Delta Sales) 1,72x 1,78x
Net Margin (Net Profit / Revenue) 8,39% 14,4%
ROA (Net Profit / Asset) 7,92% 9,98%
ROE (Net Profit / Equities) 117% 228%
Rate of Dividend 171% 98,4%
Balance Sheet Analysis 2016e 2017e
CAPEX / CA   5,67% 5,26%
Cash Flow / Sales 20,6% 23,6%
Capital Intensity (Assets / Sales) 1,06x 1,44x
Financial Leverage (Net Debt / EBITDA) 1,49x 1,32x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend